Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PPARD | Q03181 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15977306 | 1.00 | TSHR (0.56) | TSHRCYP3A4ACHEALDH1A1TP53 | |
| SCHEMBL13105856 | 0.91 | CYP3A4 (0.61) | TSHRCYP3A4 | |
| SCHEMBL733409 | 0.89 | ALDH1A1 (0.43) | TSHRCYP3A4ALDH1A1TDP1 | |
| SCHEMBL10422583 | 0.88 | TSHR (0.52) | TSHRCYP3A4ACHEALDH1A1TP53 | |
| SCHEMBL17943797 | 0.87 | CYP3A4 (0.48) | TSHRCYP3A4ACHEALDH1A1MEN1 | |
| SCHEMBL16502557 | 0.86 | TSHR (0.42) | TSHRCYP3A4ACHE | |
| SCHEMBL6847124 | 0.81 | TSHR (0.62) | TSHRACHETP53TDP1MEN1 | |
| SCHEMBL11907935 | 0.80 | CYP3A4 (0.34) | TSHRCYP3A4ALDH1A1TDP1 | |
| SCHEMBL2030636 | 0.79 | ACHE (0.38) | TSHRACHEALDH1A1TP53TDP1 | |
| SCHEMBL14582792 | 0.79 | TSHR (0.45) | TSHRCYP3A4ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114656433-A | Thioisoprophorone bridge modified double-donor organic optical nonlinear chromophore and synthetic method and application thereof | 广州大学 | 2022-06-24 | — | — | CN | claimed |
| CN-101654279-B | Amphiphilic Dispersible Nano Titanium Dioxide Material | IND TECH RES INST | 2012-03-21 | — | — | CN | claimed |
| CN-101654279-A | Amphiphilic Dispersible Nano Titanium Dioxide Material | IND TECH RES INST | 2010-02-24 | — | — | CN | claimed |
| CN-114656433-A | Thioisoprophorone bridge modified double-donor organic optical nonlinear chromophore and synthetic method and application thereof | 广州大学 | 2022-06-24 | — | — | CN | disclosed |
| US-9847549-B2 | Electrolyte and rechargeable lithium battery including same | SAMSUNG SDI CO., LTD. (KR) | 2017-12-19 | — | — | US | disclosed |
| US-9847549-B2 | Electrolyte and rechargeable lithium battery including same | SAMSUNG SDI CO., LTD. (KR) | 2017-12-19 | — | — | US | disclosed |
| US-20170237122-A1 | ELECTROLYTE FOR LITHIUM BATTERY AND LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2017-08-17 | — | — | US | disclosed |
| US-20140242453-A1 | ELECTROLYTE AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2014-08-28 | — | — | US | disclosed |
| US-20140242453-A1 | ELECTROLYTE AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2014-08-28 | — | — | US | disclosed |
| US-8445142-B2 | Organic electrolytic solution and lithium battery employing the same | SAMSUNG SDI CO., LTD. (KR) | 2013-05-21 | — | — | US | disclosed |
| CN-101654279-B | Amphiphilic Dispersible Nano Titanium Dioxide Material | IND TECH RES INST | 2012-03-21 | — | — | CN | disclosed |
| EP-0397697-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4?. | RORER INT OVERSEAS (US) | 1990-11-22 | — | — | EP | disclosed |
| EP-0395697-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4 | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1990-11-07 | — | — | EP | disclosed |
| US-4920130-A | ANTIALLERGENS, ANTIINFLAMMATORY AGENTS | RORER PHARAMCEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4920133-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| WO-1989004305-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |
| WO-1989004303-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |
| WO-1989004304-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |
| EP-0315399-A2 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1989-05-10 | — | — | EP | disclosed |